Virtu KCG Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Virtu KCG Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-33,700	Closed	-$2.32M	–	2828
2015 Q4	$2.32M	Sell	33,700 -11,500	-25%	-$760K	0.04%	350
2015 Q3	$2.68M	Buy	45,200 +6,600	+17%	+$419K	0.04%	300
2015 Q2	$2.57M	Buy	38,600 +18,100	+88%	+$1.19M	0.05%	341
2015 Q1	$1.32M	Sell	20,500 -27,600	-57%	-$1.73M	0.03%	580
2014 Q4	$2.84M	Buy	48,100 +20,100	+72%	+$1.13M	0.05%	289
2014 Q3	$1.43M	Sell	28,000 -32,400	-54%	-$1.62M	0.03%	682
2014 Q2	$2.93M	Sell	60,400 -55,300	-48%	-$2.73M	0.05%	340
2014 Q1	$6.01M	Buy	115,700 +53,000	+85%	+$2.82M	0.07%	209
2013 Q4	$3.33M	Sell	62,700 -23,000	-27%	-$1.17M	0.04%	384
2013 Q3	$3.97M	Buy	+85,700	New	+$3.76M	0.05%	302

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtu KCG Holdings's BMY Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Bristol-Myers Squibb (BMY) stake by 71% in Q2 2017, selling an estimated $2.99M and leaving 22,205 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #463.

Virtu KCG Holdings first reported a position in BMY in Q3 2013 and has held it in 16 quarters since. The position peaked at $5.84M in Q1 2015. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Virtu KCG Holdings held 22,205 shares of Bristol-Myers Squibb worth $1.24M as of Q2 2017.
Virtu KCG Holdings sold 54,994 Bristol-Myers Squibb shares in Q2 2017, an estimated $2.99M.
Bristol-Myers Squibb made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #463 holding.
Virtu KCG Holdings first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 16 quarters since.
Virtu KCG Holdings's Bristol-Myers Squibb position peaked at $5.84M in Q1 2015.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.